Showing results (1-10 of 95) with videos related to
Sort By:
Pageof 10
Neuropharmacology|August 3, 2017
Impact on GABA systems in monogenetic developmental CNS disorders: Clues to symptomatic treatmentDietmar Benke, Hanns MöhlerCurrent Protocols in Pharmacology|February 2, 2012
Benzodiazepine binding to GABA(A) receptorsDietmar Benke, Hanns MöhlerNeuropharmacology|July 8, 2008
GABA A receptors as in vivo substrate for the anxiolytic action of valerenic acid, a major constituent of valerian root extractsDietmar Benke, Andrea Barberis, Sascha Kopp, et al.Dialogues in Clinical Neuroscience|October 29, 2011
Pathophysiological aspects of diversity in neuronal inhibition: a new benzodiazepine pharmacologyHanns MöhlerAdvances in Pharmacology (San Diego, Calif.)|January 21, 2015
The legacy of the benzodiazepine receptor: from flumazenil to enhancing cognition in Down syndrome and social interaction in autismHanns MöhlerJournal of Neurochemistry|March 31, 2007
Molecular regulation of cognitive functions and developmental plasticity: impact of GABAA receptorsHanns MöhlerBiochemical Pharmacology|August 18, 2012
Cognitive enhancement by pharmacological and behavioral interventions: the murine Down syndrome modelHanns MöhlerJournal of Receptor and Signal Transduction Research|November 23, 2006
GABAA receptors in central nervous system disease: anxiety, epilepsy, and insomniaHanns MöhlerPageof 10